Amsurg Corp Com (AMSG) 80.11 $AMSG
Envision Healthcare (EVHC) in Focus: Stock Climbs 8.3% in Session
Zacks Equity Research - Zacks Investment Research - Fri Jun 10, 7:35AM CDT
Envision Healthcare Holdings, Inc. (EVHC) was a big mover last session, as the company saw its shares rise over 8% on the day.
AMSG: 80.11 (-0.89), EVHC: 27.65 (-0.15)
AmSurg Corp. to Present at Jefferies 2016 Healthcare Conference
BusinessWire - Tue Jun 07, 7:30AM CDT
AmSurg Corp. (NASDAQ: AMSG) today announced that its management will participate in the Jefferies 2016 Healthcare Conference on Wednesday, June 8, 2016, in New York. In connection with the conference, there will be an on-line simulcast and a replay of the presentation available at the Company's web site starting at 3:00 p.m. Eastern Time / 2:00 p.m. Central Time.
AMSG: 80.11 (-0.89)
AmSurg Declares Quarterly Preferred Stock Dividend
BusinessWire - Thu May 26, 3:30PM CDT
AmSurg Corp. (NASDAQ: AMSG) today announced that its Board of Directors has declared a quarterly dividend of $1.3125 per share in cash for the Company's 5.250% Mandatory Convertible Preferred Stock, Series A-1. The dividend is payable on July 1, 2016, to shareholders of record as of June 15, 2016.
AMSG: 80.11 (-0.89)
AmSurg (AMSG): Strong Q1 on Organic & Acquisition Growth
Zacks Equity Research - Zacks Investment Research - Thu May 26, 6:19AM CDT
On May 20, 2016, we issued an updated research report on Nashville, TN-based AmSurg Corp. (AMSG).
AMSG: 80.11 (-0.89), USPH: 59.40 (-0.25), LHCG: 42.75 (-0.78), HLS: 40.54 (-1.02)
AmSurg's Physician Services Division - Sheridan - Acquires Jandee Anesthesiology Partners, PLLC and Karadan Anesthesiology and Pain Management, LLP
BusinessWire - Tue May 24, 3:05PM CDT
Sheridan, the Physician Services division of AmSurg Corp. (NASDAQ: AMSG), has further expanded its anesthesiology services business through its acquisition of Jandee Anesthesiology Partners, PLLC and certain assets of Karadan Anesthesiology and Pain Management, LLP. The groups are jointly comprised of five physicians who deliver anesthesia services through a network of nine ambulatory surgery centers and other facilities in New Jersey and New York. This acquisition is complementary to Sheridan's anesthesia practices in New Jersey.
AMSG: 80.11 (-0.89)
AmSurg (AMSG) Q1 Earnings in Line, EPS Outlook Raised
Zacks Equity Research - Zacks Investment Research - Fri May 06, 9:00AM CDT
AmSurg (AMSG) started off 2016 on a satisfactory note, with its first-quarter revenue beating the Zacks Consensus Estimate while the EPS figure was in line with the mark
AMSG: 80.11 (-0.89), BSX: 23.02 (-0.30), SRDX: 23.19 (-0.11), BAX: 44.49 (-0.26)
Amsurg tops Street 1Q forecasts
Automated Insights - Tue May 03, 4:05PM CDT
NASHVILLE, Tenn. (AP) _ Amsurg Corp. (AMSG) on Tuesday reported first-quarter profit of $30.9 million.
AMSG: 80.11 (-0.89)
AmSurg Announces 27% Growth in First-Quarter Net Revenues, with Strong Same-Center and Same-Contract Revenue Growth
BusinessWire - Tue May 03, 3:05PM CDT
AmSurg Corp. (NASDAQ: AMSG) today announced financial results for the first quarter ended March 31, 2016. The Company's results for the quarter included:
AMSG: 80.11 (-0.89)
AmSurg Corp. to Present at Deutsche Bank 41st Annual Healthcare Conference
BusinessWire - Thu Apr 28, 11:30AM CDT
AmSurg Corp. (NASDAQ: AMSG) today announced that its management will participate in the Deutsche Bank 41st Annual Healthcare Conference on Thursday, May 5, 2016, in Boston, Massachusetts. In connection with the conference, there will be an on-line simulcast and a replay of the presentation available at the Company's web site starting at 12:50 p.m. Eastern Time / 11:50 a.m. Central Time.
AMSG: 80.11 (-0.89), DB: 15.74 (-0.97)
AmSurg Poised on Strategic Buyouts, Rising Costs a Concern
Zacks Equity Research - Zacks Investment Research - Wed Apr 20, 4:46PM CDT
On Apr 18, 2016, we issued an updated research report on Nashville, TN-based AmSurg Corp. (AMSG).
AMSG: 80.11 (-0.89), BSX: 23.02 (-0.30), AFAM: 42.11 (-0.81), AMED: 51.80 (-1.00)
AmSurg Corp. Sets Earnings Release and Conference Call Dates for First Quarter 2016 Results
GlobeNewswire - Tue Apr 19, 10:00AM CDT
AmSurg Corp. (Nasdaq:AMSG) today announced it will release its first quarter 2016 financial results on Tuesday, May 3, 2016, after the market closes. The Company will also host a conference call at 5:00 p.m. Eastern Time that same day. The live broadcast of AmSurg Corp.'s quarterly conference call will be available on-line by going to http://www.amsurg.com and clicking on the link to Investor Relations. The on-line replay will follow shortly after the call and continue for 30 days.
AMSG: 80.11 (-0.89)
3 Cheap Growth Stocks You Can Buy Right Now
Sean Williams, The Motley Fool - Motley Fool - Wed Mar 23, 9:05AM CDT
Image source: Pixabay. While the market was in nearly nonstop rally mode for most of the past six years, investors didn't need to look far to uncover an abundance of growth stocks. But not all growth stocks are created equal. While some look poised...
AMSG: 80.11 (-0.89), DW: 79.00 (-1.43), AVGO: 160.82 (-3.32)
AmSurg: Strong Q4 Raises Hope amid Bleak Cash Balance
Zacks Equity Research - Zacks Investment Research - Tue Mar 01, 1:20PM CST
AmSurg (AMSG) ended 2015 on an impressive note with its fourth-quarter results squarely beating the Zacks Consensus Estimate.
AMSG: 80.11 (-0.89), VASC: 39.58 (-0.56), HRC: 50.10 (-1.12), OSUR: 7.78 (-0.13)
Amsurg Down 20.3% Since SmarTrend Downtrend Call (AMSG)
Comtex SmarTrend(R) - Tue Feb 09, 9:47AM CST
SmarTrend identified a Downtrend for Amsurg (NASDAQ:AMSG) on December 21st, 2015 at $77.06. In approximately 2 months, Amsurg has returned 20.26% as of today's recent price of $61.44.
AMSG: 80.11 (-0.89)
Short Interest Expands By 27.4% For AMSG
MarketNewsVideo.com - Thu Jan 14, 2:33PM CST
The most recent short interest data has been released by the NASDAQ for the 12/31/2015 settlement date, which shows a 819,435 share increase in total short interest for AmSurg Corp , to 3,812,731, an increase of 27.38% since 12/15/2015. Total short...
AMSG: 80.11 (-0.89)
AmSurg Sees Balanced Growth amid Escalating Expenses
Zacks Equity Research - Zacks Investment Research - Fri Jan 08, 1:30PM CST
On Jan 6, 2015, we issued an updated research report on AmSurg Corporation (AMSG).
AMSG: 80.11 (-0.89), PMC: 26.43 (-0.66), CO: 5.92 (-0.06)
AmSurg Corp. to Present at 34th Annual J.P. Morgan Healthcare Conference
BusinessWire - Wed Jan 06, 10:00AM CST
AmSurg Corp. (NASDAQ: AMSG) today announced that it will participate in the 34th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13, 2016, in San Francisco, California. In connection with the conference, there will be an on-line simulcast and a replay of the presentation available at the Company's web site starting at 8:00 a.m. Pacific Time / 10:00 a.m. Central Time. Christopher A. Holden, President and Chief Executive Officer, Claire M. Gulmi, Executive Vice President and Chief Financial Officer, and Bob Coward, Physician Services President and Chief Development Officer, will be speaking at the conference.
AMSG: 80.11 (-0.89), JPM: 63.84 (-0.91)
Envision Healthcare (EVHC) in Focus: Stock Climbs 8.3% in Session
Zacks Equity Research - Zacks Investment Research - Fri Jun 10, 7:35AM CDT
Envision Healthcare Holdings, Inc. (EVHC) was a big mover last session, as the company saw its shares rise over 8% on the day.
AMSG: 80.11 (-0.89), EVHC: 27.65 (-0.15)
AmSurg Corp. to Present at Jefferies 2016 Healthcare Conference
BusinessWire - Tue Jun 07, 7:30AM CDT
AmSurg Corp. (NASDAQ: AMSG) today announced that its management will participate in the Jefferies 2016 Healthcare Conference on Wednesday, June 8, 2016, in New York. In connection with the conference, there will be an on-line simulcast and a replay of the presentation available at the Company's web site starting at 3:00 p.m. Eastern Time / 2:00 p.m. Central Time.
AMSG: 80.11 (-0.89)
AmSurg Declares Quarterly Preferred Stock Dividend
BusinessWire - Thu May 26, 3:30PM CDT
AmSurg Corp. (NASDAQ: AMSG) today announced that its Board of Directors has declared a quarterly dividend of $1.3125 per share in cash for the Company's 5.250% Mandatory Convertible Preferred Stock, Series A-1. The dividend is payable on July 1, 2016, to shareholders of record as of June 15, 2016.
AMSG: 80.11 (-0.89)
AmSurg (AMSG): Strong Q1 on Organic & Acquisition Growth
Zacks Equity Research - Zacks Investment Research - Thu May 26, 6:19AM CDT
On May 20, 2016, we issued an updated research report on Nashville, TN-based AmSurg Corp. (AMSG).
AMSG: 80.11 (-0.89), USPH: 59.40 (-0.25), LHCG: 42.75 (-0.78), HLS: 40.54 (-1.02)
AmSurg's Physician Services Division - Sheridan - Acquires Jandee Anesthesiology Partners, PLLC and Karadan Anesthesiology and Pain Management, LLP
BusinessWire - Tue May 24, 3:05PM CDT
Sheridan, the Physician Services division of AmSurg Corp. (NASDAQ: AMSG), has further expanded its anesthesiology services business through its acquisition of Jandee Anesthesiology Partners, PLLC and certain assets of Karadan Anesthesiology and Pain Management, LLP. The groups are jointly comprised of five physicians who deliver anesthesia services through a network of nine ambulatory surgery centers and other facilities in New Jersey and New York. This acquisition is complementary to Sheridan's anesthesia practices in New Jersey.
AMSG: 80.11 (-0.89)
AmSurg (AMSG) Q1 Earnings in Line, EPS Outlook Raised
Zacks Equity Research - Zacks Investment Research - Fri May 06, 9:00AM CDT
AmSurg (AMSG) started off 2016 on a satisfactory note, with its first-quarter revenue beating the Zacks Consensus Estimate while the EPS figure was in line with the mark
AMSG: 80.11 (-0.89), BSX: 23.02 (-0.30), SRDX: 23.19 (-0.11), BAX: 44.49 (-0.26)
Amsurg tops Street 1Q forecasts
Automated Insights - Tue May 03, 4:05PM CDT
NASHVILLE, Tenn. (AP) _ Amsurg Corp. (AMSG) on Tuesday reported first-quarter profit of $30.9 million.
AMSG: 80.11 (-0.89)
AmSurg Announces 27% Growth in First-Quarter Net Revenues, with Strong Same-Center and Same-Contract Revenue Growth
BusinessWire - Tue May 03, 3:05PM CDT
AmSurg Corp. (NASDAQ: AMSG) today announced financial results for the first quarter ended March 31, 2016. The Company's results for the quarter included:
AMSG: 80.11 (-0.89)
AmSurg Corp. to Present at Deutsche Bank 41st Annual Healthcare Conference
BusinessWire - Thu Apr 28, 11:30AM CDT
AmSurg Corp. (NASDAQ: AMSG) today announced that its management will participate in the Deutsche Bank 41st Annual Healthcare Conference on Thursday, May 5, 2016, in Boston, Massachusetts. In connection with the conference, there will be an on-line simulcast and a replay of the presentation available at the Company's web site starting at 12:50 p.m. Eastern Time / 11:50 a.m. Central Time.
AMSG: 80.11 (-0.89), DB: 15.74 (-0.97)
AmSurg Poised on Strategic Buyouts, Rising Costs a Concern
Zacks Equity Research - Zacks Investment Research - Wed Apr 20, 4:46PM CDT
On Apr 18, 2016, we issued an updated research report on Nashville, TN-based AmSurg Corp. (AMSG).
AMSG: 80.11 (-0.89), BSX: 23.02 (-0.30), AFAM: 42.11 (-0.81), AMED: 51.80 (-1.00)
AmSurg Corp. Sets Earnings Release and Conference Call Dates for First Quarter 2016 Results
GlobeNewswire - Tue Apr 19, 10:00AM CDT
AmSurg Corp. (Nasdaq:AMSG) today announced it will release its first quarter 2016 financial results on Tuesday, May 3, 2016, after the market closes. The Company will also host a conference call at 5:00 p.m. Eastern Time that same day. The live broadcast of AmSurg Corp.'s quarterly conference call will be available on-line by going to http://www.amsurg.com and clicking on the link to Investor Relations. The on-line replay will follow shortly after the call and continue for 30 days.
AMSG: 80.11 (-0.89)
3 Cheap Growth Stocks You Can Buy Right Now
Sean Williams, The Motley Fool - Motley Fool - Wed Mar 23, 9:05AM CDT
Image source: Pixabay. While the market was in nearly nonstop rally mode for most of the past six years, investors didn't need to look far to uncover an abundance of growth stocks. But not all growth stocks are created equal. While some look poised...
AMSG: 80.11 (-0.89), DW: 79.00 (-1.43), AVGO: 160.82 (-3.32)
AmSurg: Strong Q4 Raises Hope amid Bleak Cash Balance
Zacks Equity Research - Zacks Investment Research - Tue Mar 01, 1:20PM CST
AmSurg (AMSG) ended 2015 on an impressive note with its fourth-quarter results squarely beating the Zacks Consensus Estimate.
AMSG: 80.11 (-0.89), VASC: 39.58 (-0.56), HRC: 50.10 (-1.12), OSUR: 7.78 (-0.13)
Amsurg Down 20.3% Since SmarTrend Downtrend Call (AMSG)
Comtex SmarTrend(R) - Tue Feb 09, 9:47AM CST
SmarTrend identified a Downtrend for Amsurg (NASDAQ:AMSG) on December 21st, 2015 at $77.06. In approximately 2 months, Amsurg has returned 20.26% as of today's recent price of $61.44.
AMSG: 80.11 (-0.89)
Short Interest Expands By 27.4% For AMSG
MarketNewsVideo.com - Thu Jan 14, 2:33PM CST
The most recent short interest data has been released by the NASDAQ for the 12/31/2015 settlement date, which shows a 819,435 share increase in total short interest for AmSurg Corp , to 3,812,731, an increase of 27.38% since 12/15/2015. Total short...
AMSG: 80.11 (-0.89)
AmSurg Sees Balanced Growth amid Escalating Expenses
Zacks Equity Research - Zacks Investment Research - Fri Jan 08, 1:30PM CST
On Jan 6, 2015, we issued an updated research report on AmSurg Corporation (AMSG).
AMSG: 80.11 (-0.89), PMC: 26.43 (-0.66), CO: 5.92 (-0.06)
AmSurg Corp. to Present at 34th Annual J.P. Morgan Healthcare Conference
BusinessWire - Wed Jan 06, 10:00AM CST
AmSurg Corp. (NASDAQ: AMSG) today announced that it will participate in the 34th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13, 2016, in San Francisco, California. In connection with the conference, there will be an on-line simulcast and a replay of the presentation available at the Company's web site starting at 8:00 a.m. Pacific Time / 10:00 a.m. Central Time. Christopher A. Holden, President and Chief Executive Officer, Claire M. Gulmi, Executive Vice President and Chief Financial Officer, and Bob Coward, Physician Services President and Chief Development Officer, will be speaking at the conference.
AMSG: 80.11 (-0.89), JPM: 63.84 (-0.91)
